Clinical Trial Update: Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dolutegravir to darunavir/ritonavir, each with dual NRTIs, in ART-naive HIV patients; completed with posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2014-03-27